I'll start by reading the initial read set files to understand the task contract and context.

I'm `worker_02`, assigned work item 2 (minimal implementation). First, let me explore the repository structure to understand the existing package pattern (packages 75-80).

The pattern is clear. Let me read the package 81 execution contract and explore the existing package 75-80 pattern directory.

The pattern is established. Let me examine the package 80 artifacts (closest prior pattern) in detail.

Now let me look at the test pattern and the config directory to understand the full set of artifacts for packages 75-80.

Let me look at the execution subfolder and the main replay script to understand how the preparation evidence is generated.

Now let me understand the replay script CLI and how the preparation evidence gets generated.

Let me check the package 75 config for structural differences and look at the test file pattern.

Let me write a simple comparison script to check config key structures across packages 75-80.

Config schema is consistent for packages 76-80. Now let me examine the frozen plan content for `body.p1027-p1032` — the source of truth for package 81.

Let me check what the `body.t7.r0` context unit is in the frozen package, and look at how package 80's config handled its similar context.

The `body.t7.r0` in context is the phase III estimates table header, not the AE Table 7. Let me verify what Table 7 in the AE section maps to in the coverage manifest.

Table 7 content is `body.t12.r0-r4`. Let me check package 82's ownership to confirm the boundary.

Boundaries are now clear: package 81 owns `p1027-p1032`; Table 7 (`t12.r0-r4`) belongs to package 82. Now let me study the test pattern — starting with the package 80 test's structure.

Now let me check git history to see the exact artifact sequence per package, and look at the review notes for package 80.

Let me read the review file for the package 80 execution and check the workspace journal for the established pattern.

No pre-existing package 81 artifacts. Let me understand `_resolve_units` to see how rows are resolved from config vs frozen plan.

Let me compare attached closures across packages 75-79 to understand the closure progression pattern.

Now let me look at the metrics for package 80's execution to see the exact commands run, and check the test setup.

I have the full template. Now let me pull the exact excerpts for the planned attached refs (p985-p1026 + anchors) to lock verbatim assertions.

All excerpts verified. Let me confirm ownership mapping of all planned attached refs in the frozen plan.

All evidence gathered. Let me set up my task tracking and then create the package 81 artifacts.

Let me check the `_clinical_qc_scaffold` and `evaluate_prepare_source_closure` requirements in the harness to ensure config completeness.

The prepare gate requires all owned+attached refs to resolve. Package 81's owned refs are all in the frozen plan as owned; my planned attached refs (p985-p1026 owned by 77-80; p340/p835/p885/p315/p318 context) all resolve. Let me get structure unit IDs for the owned units, then write the config.

All evidence gathered. Now creating the package 81 config.

Config created. Let me validate it loads and runs the dry-run prepare to generate the model-out preparation evidence.

Prepare evidence generated: 6 owned / 47 attached / 53 total. Let me verify the generated files.

Let me verify the prompt contains key semantics and does NOT leak table 7 rules.

Prompt verified clean. Now the parent checklist.

Now the test file. Let me first verify the matrix/catalog fixtures used by package 80's test exist and check the `_clinical_qc_scaffold` for any structural requirements.

Now writing the dedicated test file for package 81.

Now run the package 81 dedicated test.

One test failure — my "呕吐" leak marker is too broad (p1000 attached source legitimately contains "恶心、呕吐"). Fixing the leak check to Table-7-specific fragments only.

All 35 pass. Now the adjacent regression suite (packages 75-80 + shared suites).

Adjacent regressions pass. Now the full phase-closure directory.

All 288 pass. Let me verify the count delta matches exactly the new test file, and confirm config/prepare evidence consistency.

Baseline 253 + 35 new = 288, matching Codex's phase-closure baseline. Now let me verify the generated evidence coherence and compute the config SHA.

All evidence is coherent. Let me verify no shared code was modified and confirm the new artifacts set.

The entire `.trellis/` tree is untracked in this worktree (same as prior packages); my writes were limited to the 4 authorized paths. Let me do a final validation of the QC scaffold and prompt meta.

The QC scaffold key may differ from the config key. Let me compare with package 80's clinical-qc.json.

Structure matches package 80 exactly. Let me confirm the QC checks are embedded in the rows.

Package 80 has identical structure (rows carry `codex_clinical_checks` placeholders that Codex fills during review) — my package 81 run matches the established pattern exactly. All work is complete.

All work complete. Final report follows.

---

# Execution Output: phase5-slice61bs-package81-ae-diagnosis-secondary-event-boundary - worker_02

## Boundary And Context Check

- **Fallback declaration**: I am the declared same-platform fallback `codebuddy-cli` / `deepseek-v4-flash` (primary `glm-5.3-flash` was unavailable before a resumable session existed). Delegated mode remained in effect; I preserved the bounded role, initial read set, task contract, quality gates, and conference-pass protocol. No capability limitation affected this work — config authoring, deterministic tests, and harness dry-run are all within this model's tools.
- **Initial read set**: read `context/phase5-slice61bs-package81-ae-diagnosis-secondary-event-boundary_execution_context.md` and `plans/codex_execution_phase5-slice61bs-package81-ae-diagnosis-secondary-event-boundary.md`. Work item 2 (worker_02) assigned and executed.
- **Hard boundaries honored**: worked only inside the runner CWD; no production paths read or written; no source protocol, official matrix, or shared harness file modified; no model/Agent invoked (dry-run prepare only); no subject/OCR/case review; `claims_complete=false` maintained. Did not create the runner-managed report file and no sibling process files.
- **Additional evidence read (within workspace)**: frozen plan `frozen_phase_plan.json`, coverage manifest, structure blob, official flow-controls matrix, procedure catalog, package 80 worker report/checklist/config/test as the template basis, and the package 75-80 configs for the closure progression. All recorded as evidence, none as instructions.
- **Inference vs evidence**: package-81 ownership (6 units `body.p1027-p1032`, id `pap-d284831618aa0dcf855c35d7`) is direct frozen-plan evidence; the attached closure composition (47 refs) is my minimal-closure design choice based on textual dependency, following the established package 77-80 pattern — Codex retains authority over closure sufficiency.

## Work Performed

Based on the frozen 131-package plan (plan `papl-40b1237a22e538a278b4fd5e`, package 81 `pap-d284831618aa0dcf855c35d7`, owned units `body.p1027-p1032`, 6 units) I created the minimal model-free real-source closure for package 81 and its deterministic guard:

1. **Config** `configs/representative_group_package81_ae_diagnosis_secondary_event_boundary.v1.json`:
   - `owned_source_refs` = `body.p1027-p1032` (6): 诊断与症状、体征和检查值 heading (p1027), 诊断术语优先 (p1028), 暂无法诊断记录路径与后续诊断更新 (p1029), 继发事件 heading (p1030), 主要原因判断 (p1031), 表7表题 (p1032).
   - `structural_only_source_refs` (3 heading/caption units): p1027, p1030, p1032 — chapter titles/table caption only, no independent control point; the 3 semantic units (p1028/p1029/p1031) keep `post_treatment_execution` disposition.
   - `attached_source_refs` (47, all read-only): package 77 AE/TEAE block `p985-p994`; package 78 SAE block `p995-p1006`; package 79 SAE tail `p1007-p1014`; package 80 ADR/SUSAR + AE collection/recording `p1015-p1026` (incl. p1026 单一事件项一术语, upstream of p1028 术语偏好); flow anchors `p340`/`p835`/`p885`; ICF anchor `p315`; history-collection anchor `p318`.
   - `required_candidate_source_refs=[]`; all 6 owned refs forbidden from emitting candidates (11 forbidden-upgrade markers each); `exception_semantics_by_source_ref` locks: p1028 诊断优先是偏好非强制确诊 + 合并限定"可称为或归属于一种疾病或者损害的表现"; p1029 暂无法诊断并列记录路径 + 后续诊断更新三要素（单一诊断1例次/取代之前记录/首次症状日期）; p1031 只保留"根据主要原因判断是否独立记录"及表7引用, 不得补写表7四类规则.
   - `later_package_boundary`: `expected_owners_by_span` t12.r0-r4 → 82, p1033-p1042 → 83, p1043-p1054 → 84, **not attached and not owned** (minimal closure — no textual dependency); note documents non-absorption of package 82-84, 85-86 特殊肝功能SAE, 90 因果共同判断, 92-99 报告时限与流程 (24小时报告).
2. **Parent clinical checklist** `slice61bs-package81-ae-diagnosis-secondary-event-boundary-parent-checklist.md`: boundary, rationale (7 risk items), per-source responsibility table (6 owned + 47 attached), 15-item blind parent checklist, success/stop conditions, immutable fingerprints, pre-replay decisions.
3. **Deterministic tests** `test_slice61bs_package81_ae_diagnosis_secondary_event_boundary.py` (35 tests), locking:
   - config contract; owned == frozen package 81; structural titles separate from semantic units; attached == 47 read-only with documented ownership (p985-p994→77, p995-p1006→78, p1007-p1014→79, p1015-p1026→80, p835→75, p315/p318/p340/p885 unowned context; t12→82, p1033-p1042→83, p1043-p1054→84).
   - verbatim owned excerpts (all 6); resolution role/excerpt checks; prepare evidence (6 owned + 47 attached in prompt); hydrated zero-candidate gate with counterexamples (CONTROL_DUPLICATE_RETAINED / DISPOSITION_MISMATCH).
   - p1028 诊断优先 gate: 强制确诊/无诊断不得记录/拆并扩写 counterexamples all rejected; merge qualifier 保留; p1026 单一事件项规范未被吞并.
   - p1029 gate: 记录路径收窄 counterexamples rejected; 后续诊断更新三要素（含首次症状日期）丢失 counterexamples rejected.
   - p1031 gate: 一律独立/一律合并/无需判断 counterexamples rejected; 表7四类规则未泄漏进提示（用表7独有行文"事件B1"/"健康成人轻度脱水"等验证, 避免与p1000合法摘录"恶心、呕吐"冲突）.
   - Forbidden-upgrade gate with per-ref screening/baseline counterexamples and no false positives on legitimate source text.
   - Official matrix: zero rows anchored in p985-p1054, zero 不良事件/TEAE/SAE rows; procedure catalog no AE node and no definition-span sources; known targets empty; workflow stages keep D1 pre-dose distinct; immutable fingerprints; checklist freeze.
4. **Prepare evidence** (generated by harness `--dry-run`, not hand-written): `slice59n-prepare/d001-ii-package81-ae-diagnosis-secondary-event-boundary/` with `source_rows.json`, `replay-summary.json`, `freeze_provenance.json`, `clinical-qc.json`, `execution/{batch.json, prompt-meta.json, prompt.txt}` (52,465-char prompt; verified to contain all key semantics and zero table-7 row content).

## Artifacts And Evidence

| Artifact | Path (under `research/d001-ii-phase-closure/`) | Status |
|---|---|---|
| Config | `configs/representative_group_package81_ae_diagnosis_secondary_event_boundary.v1.json` | created, config SHA-256 `993934451be2d8d0f11f5d07eca6eeeff5da92010d1e9c82d9f68cad0d5f0fe6` |
| Checklist | `slice61bs-package81-ae-diagnosis-secondary-event-boundary-parent-checklist.md` | created |
| Tests | `test_slice61bs_package81_ae_diagnosis_secondary_event_boundary.py` | created, 35 passed |
| Prepare evidence | `slice59n-prepare/d001-ii-package81-ae-diagnosis-secondary-event-boundary/` (7 files) | generated by harness `--dry-run` |

Key evidence numbers: prepare `owned=6`, `attached=47`, `unit=53`, `prompt=52465` chars, `prompt_sha256=2bea0582…`, `claims_complete=false`; lookup counts `frozen_plan_owned=49`, `frozen_plan_context=4`; control batch `pcb-fee4a2a6…`; official matrix zero rows anchored in p985-p1054; package 82 owns t12.r0-r4 (5), package 83 owns p1033-p1042 (10), package 84 owns p1043-p1054 (12) per frozen plan; prompt contains no table-7 row content (verified).

## Commands And Observations

- `slice59n_representative_group_control_replay.py --config configs/representative_group_package81_ae_diagnosis_secondary_event_boundary.v1.json --dry-run` (venv python 3.12) → succeeded first run; summary printed with expected counts (6/47/53).
- `pytest test_slice61bs_package81_ae_diagnosis_secondary_event_boundary.py -q` → **35 passed, 5 warnings** (first run 1 failure: my table-7 leak marker "呕吐" false-positived on the legitimately attached p1000 SAE excerpt "头痛、恶心、呕吐、腹泻"; fixed the marker to table-7-only wording).
- Adjacent regressions (packages 75-80 tests + `test_slice59n_representative_group_regressions.py` + `test_matrix_source_closure.py` + `test_slice61bk_efficacy_source_closure.py`) → **249 passed, 5 warnings**.
- Full phase-closure directory (`test_*.py`) → **288 passed, 5 warnings** (baseline 253 + 35 new).
- Observation: `.trellis/` is untracked in this worktree (same as packages 79-80's runs); all created artifacts are inside `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/`, matching the established pattern; no shared code (app/, scripts/, harness) was modified.

## Blockers Or Missing Environment

- None. The project venv (`.venv/bin/python`, 3.12.13) was required and present; all runs used it explicitly.
- Remaining unverified by design (Codex authority): no clinical semantic replay was run, no subject/case review, no Patient Journey classification, no browser/visual checks — per the slice contract (`claims_complete=false`).

## Rerun Requests Or Next Step

- None from this worker. Codex may proceed to review worker_01 (source/ownership) and worker_03 (adversarial challenge) outputs, then run the方案与 Agent full suite and governance audit as listed in the package-80 acceptance precedent. If Codex decides the 47-ref attached closure is larger than necessary, the minimal trimming point is the package 77-79 chain (p985-p1014); my design follows the established package-80 pattern of attaching the full preceding definitional chain.
